According to the Drug Administration Law of the People's Republic of China, the Pharmacopoeia of the People's Republic of China (2025 Edition) (hereinafter referred to as Chinese Pharmacopoeia) has been reviewed and approved by the Plenary Meeting of the Executive Committee of the 12th Chinese Pharmacopoeia Commission. It is hereby issued and shall come into force as of October 01, 2025. For the contents of the Chinese Pharmacopoeia (2025 Edition), see the attachment.

It is hereby announced.

National Medical Products Administration    National Health Commission

March 20, 2025